<SEC-DOCUMENT>0000899243-23-005241.txt : 20230216
<SEC-HEADER>0000899243-23-005241.hdr.sgml : 20230216
<ACCEPTANCE-DATETIME>20230216160515
ACCESSION NUMBER:		0000899243-23-005241
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230215
FILED AS OF DATE:		20230216
DATE AS OF CHANGE:		20230216

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Izumi Raquel E.
		CENTRAL INDEX KEY:			0001832553

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39244
		FILM NUMBER:		23638527

	MAIL ADDRESS:	
		STREET 1:		4500 GREAT AMERICA PKWY
		STREET 2:		STE. 100 #29
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vincerx Pharma, Inc.
		CENTRAL INDEX KEY:			0001796129
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				833197402
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		260 SHERIDAN AVENUE
		STREET 2:		SUITE 400
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306
		BUSINESS PHONE:		650-800-6676

	MAIL ADDRESS:	
		STREET 1:		260 SHERIDAN AVENUE
		STREET 2:		SUITE 400
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vincera Pharma, Inc.
		DATE OF NAME CHANGE:	20201223

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LifeSci Acquisition Corp.
		DATE OF NAME CHANGE:	20191206
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2023-02-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001796129</issuerCik>
        <issuerName>Vincerx Pharma, Inc.</issuerName>
        <issuerTradingSymbol>VINC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001832553</rptOwnerCik>
            <rptOwnerName>Izumi Raquel E.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>260 SHERIDAN AVENUE, SUITE 400</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>PALO ALTO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94306</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See Remarks</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.17</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2023-02-15</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>90000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2033-02-14</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>90000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>90000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Option vests in twenty-four equal monthly installments starting from February 15, 2023.</footnote>
    </footnotes>

    <remarks>President and Chief Operations Officer

Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.</remarks>

    <ownerSignature>
        <signatureName>By: /s/ Raquel E. Izumi</signatureName>
        <signatureDate>2023-02-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
